| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 36 | 2025 | 171 | 5.890 |
Why?
|
| Lupus Nephritis | 6 | 2025 | 37 | 2.010 |
Why?
|
| Autoantibodies | 14 | 2025 | 184 | 1.820 |
Why?
|
| Antibodies, Antinuclear | 7 | 2023 | 39 | 1.760 |
Why?
|
| Glomerulonephritis | 4 | 2017 | 32 | 1.700 |
Why?
|
| Apoptosis | 15 | 2014 | 1094 | 1.550 |
Why?
|
| Autoimmunity | 7 | 2025 | 240 | 1.410 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2025 | 102 | 1.070 |
Why?
|
| Estradiol | 4 | 2018 | 258 | 0.980 |
Why?
|
| Antigens, CD19 | 1 | 2025 | 25 | 0.950 |
Why?
|
| Autoantigens | 5 | 2020 | 137 | 0.930 |
Why?
|
| Poly(ADP-ribose) Polymerases | 5 | 2015 | 32 | 0.920 |
Why?
|
| Macrophage Activation Syndrome | 1 | 2024 | 5 | 0.840 |
Why?
|
| Necrosis | 3 | 2014 | 144 | 0.790 |
Why?
|
| Neutrophils | 1 | 2025 | 378 | 0.750 |
Why?
|
| Respiration, Artificial | 2 | 2021 | 296 | 0.710 |
Why?
|
| Dendritic Cells | 7 | 2019 | 528 | 0.680 |
Why?
|
| Kidney | 6 | 2024 | 455 | 0.670 |
Why?
|
| Bacteriuria | 1 | 2020 | 16 | 0.670 |
Why?
|
| Interleukin-1beta | 2 | 2022 | 271 | 0.670 |
Why?
|
| Pulmonologists | 1 | 2020 | 5 | 0.650 |
Why?
|
| Rheumatologists | 1 | 2020 | 7 | 0.650 |
Why?
|
| Immunity, Innate | 3 | 2025 | 803 | 0.650 |
Why?
|
| Signal Transduction | 5 | 2021 | 3070 | 0.650 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 210 | 0.650 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 223 | 0.640 |
Why?
|
| fas Receptor | 6 | 2011 | 57 | 0.610 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 247 | 0.600 |
Why?
|
| Energy Metabolism | 2 | 2019 | 384 | 0.560 |
Why?
|
| Escherichia coli | 2 | 2020 | 718 | 0.550 |
Why?
|
| Estrogen Receptor alpha | 1 | 2017 | 49 | 0.540 |
Why?
|
| Pandemics | 3 | 2021 | 676 | 0.510 |
Why?
|
| Autoimmune Diseases | 6 | 2024 | 233 | 0.510 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2016 | 15 | 0.490 |
Why?
|
| Mice | 28 | 2025 | 11003 | 0.490 |
Why?
|
| Humans | 52 | 2025 | 64238 | 0.490 |
Why?
|
| HMGB1 Protein | 1 | 2016 | 26 | 0.490 |
Why?
|
| Mesangial Cells | 1 | 2015 | 2 | 0.460 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 15 | 0.460 |
Why?
|
| Cytokines | 6 | 2024 | 944 | 0.460 |
Why?
|
| Phagocytosis | 4 | 2005 | 266 | 0.450 |
Why?
|
| Animals | 32 | 2025 | 20961 | 0.450 |
Why?
|
| Membrane Glycoproteins | 5 | 2020 | 671 | 0.440 |
Why?
|
| B-Lymphocytes | 8 | 2025 | 571 | 0.440 |
Why?
|
| Estrogens | 1 | 2015 | 116 | 0.430 |
Why?
|
| Germinal Center | 3 | 2025 | 39 | 0.420 |
Why?
|
| Deoxyribonucleases | 2 | 2011 | 32 | 0.420 |
Why?
|
| DNA Fragmentation | 3 | 2007 | 34 | 0.380 |
Why?
|
| Female | 35 | 2025 | 33350 | 0.370 |
Why?
|
| Ultraviolet Rays | 3 | 2003 | 141 | 0.360 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 2 | 2021 | 13 | 0.340 |
Why?
|
| Oxidative Stress | 2 | 2025 | 304 | 0.330 |
Why?
|
| Inflammasomes | 2 | 2025 | 342 | 0.320 |
Why?
|
| Lymphocyte Activation | 5 | 2020 | 761 | 0.320 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 2238 | 0.310 |
Why?
|
| Interferon Type I | 4 | 2020 | 187 | 0.310 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1551 | 0.300 |
Why?
|
| Sex Factors | 4 | 2018 | 979 | 0.280 |
Why?
|
| Male | 21 | 2023 | 30294 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 13 | 2025 | 3450 | 0.260 |
Why?
|
| Mice, Knockout | 6 | 2025 | 2140 | 0.260 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 783 | 0.260 |
Why?
|
| Interferons | 2 | 2021 | 73 | 0.250 |
Why?
|
| Inflammation | 3 | 2021 | 1162 | 0.250 |
Why?
|
| Middle Aged | 15 | 2023 | 17898 | 0.250 |
Why?
|
| Chromatin | 3 | 2007 | 616 | 0.240 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2025 | 260 | 0.240 |
Why?
|
| Symptom Flare Up | 1 | 2025 | 16 | 0.240 |
Why?
|
| Methylprednisolone | 1 | 2025 | 38 | 0.240 |
Why?
|
| Opsonin Proteins | 1 | 2005 | 30 | 0.230 |
Why?
|
| T-Lymphocytes | 3 | 2025 | 1019 | 0.230 |
Why?
|
| Cells, Cultured | 7 | 2019 | 2176 | 0.230 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2025 | 33 | 0.230 |
Why?
|
| Plasma Cells | 1 | 2025 | 52 | 0.220 |
Why?
|
| Extracellular Traps | 1 | 2025 | 44 | 0.220 |
Why?
|
| Young Adult | 3 | 2025 | 4776 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 217 | 0.220 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 2 | 2015 | 18 | 0.210 |
Why?
|
| Phagocytes | 1 | 2004 | 52 | 0.210 |
Why?
|
| Disease Progression | 4 | 2021 | 1176 | 0.210 |
Why?
|
| Survival Rate | 2 | 2021 | 859 | 0.210 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 237 | 0.210 |
Why?
|
| Interferon-alpha | 1 | 2024 | 103 | 0.210 |
Why?
|
| DNA, Z-Form | 1 | 2023 | 1 | 0.210 |
Why?
|
| DNA, B-Form | 1 | 2023 | 3 | 0.210 |
Why?
|
| ErbB Receptors | 1 | 2024 | 120 | 0.210 |
Why?
|
| Immunosuppressive Agents | 1 | 2025 | 381 | 0.200 |
Why?
|
| Antigen Presentation | 1 | 2005 | 241 | 0.200 |
Why?
|
| Models, Genetic | 1 | 2004 | 261 | 0.200 |
Why?
|
| Gene Expression | 2 | 2017 | 851 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 189 | 0.200 |
Why?
|
| Treatment Outcome | 2 | 2025 | 5691 | 0.190 |
Why?
|
| Double-Blind Method | 2 | 2021 | 744 | 0.190 |
Why?
|
| Culture Media, Serum-Free | 1 | 2002 | 10 | 0.190 |
Why?
|
| Ceramides | 1 | 2002 | 24 | 0.180 |
Why?
|
| Ferritins | 1 | 2021 | 31 | 0.180 |
Why?
|
| Betacoronavirus | 2 | 2020 | 183 | 0.170 |
Why?
|
| Severity of Illness Index | 5 | 2020 | 1561 | 0.170 |
Why?
|
| Adult | 14 | 2023 | 17116 | 0.170 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2021 | 48 | 0.170 |
Why?
|
| Endogenous Retroviruses | 1 | 2021 | 12 | 0.170 |
Why?
|
| Aged | 6 | 2021 | 14648 | 0.170 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 785 | 0.170 |
Why?
|
| Etoposide | 1 | 2020 | 33 | 0.170 |
Why?
|
| Lymphocytes | 3 | 2011 | 203 | 0.170 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 374 | 0.160 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 166 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 423 | 0.160 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 36 | 0.160 |
Why?
|
| Fas Ligand Protein | 4 | 2002 | 42 | 0.160 |
Why?
|
| Vitamin K | 1 | 1999 | 16 | 0.160 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2020 | 112 | 0.150 |
Why?
|
| Interleukin-27 | 1 | 2019 | 6 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 2020 | 113 | 0.150 |
Why?
|
| Pyruvates | 1 | 2019 | 3 | 0.150 |
Why?
|
| Universities | 1 | 2020 | 164 | 0.150 |
Why?
|
| Immunomodulation | 1 | 2019 | 32 | 0.150 |
Why?
|
| Disease Susceptibility | 2 | 2017 | 165 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 172 | 0.140 |
Why?
|
| Feces | 1 | 2019 | 116 | 0.140 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 176 | 0.140 |
Why?
|
| Interleukin-10 | 1 | 2019 | 161 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 1162 | 0.140 |
Why?
|
| Bacterial Infections | 1 | 2019 | 153 | 0.140 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 182 | 0.140 |
Why?
|
| Ligands | 4 | 2019 | 417 | 0.140 |
Why?
|
| Antigen-Antibody Complex | 1 | 2017 | 52 | 0.140 |
Why?
|
| Interferon-gamma | 1 | 2020 | 576 | 0.130 |
Why?
|
| Jurkat Cells | 4 | 2005 | 110 | 0.130 |
Why?
|
| Forecasting | 1 | 2018 | 233 | 0.130 |
Why?
|
| Biomarkers | 3 | 2020 | 1431 | 0.130 |
Why?
|
| Terpenes | 2 | 2007 | 30 | 0.130 |
Why?
|
| Graft vs Host Disease | 1 | 2017 | 116 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 161 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2018 | 272 | 0.120 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 37 | 0.120 |
Why?
|
| Urinalysis | 1 | 2016 | 38 | 0.120 |
Why?
|
| Cell Differentiation | 2 | 2025 | 1365 | 0.120 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 223 | 0.120 |
Why?
|
| Creatinine | 1 | 2016 | 133 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2015 | 62 | 0.120 |
Why?
|
| Computational Biology | 1 | 2017 | 357 | 0.120 |
Why?
|
| Lipopolysaccharides | 3 | 2019 | 624 | 0.120 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2021 | 72 | 0.120 |
Why?
|
| Avian Proteins | 1 | 2015 | 7 | 0.110 |
Why?
|
| Salmonella Infections | 1 | 2015 | 42 | 0.110 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 46 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 462 | 0.110 |
Why?
|
| Th1 Cells | 1 | 2015 | 173 | 0.110 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 50 | 0.110 |
Why?
|
| RNA Polymerase II | 1 | 2015 | 87 | 0.110 |
Why?
|
| Amyloid | 1 | 2015 | 70 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 153 | 0.110 |
Why?
|
| Phospholipids | 2 | 2021 | 82 | 0.110 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 86 | 0.110 |
Why?
|
| Escherichia coli Infections | 1 | 2015 | 89 | 0.110 |
Why?
|
| Calcium Channels | 1 | 2015 | 103 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 260 | 0.110 |
Why?
|
| Mice, Inbred NZB | 3 | 2024 | 21 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2020 | 2604 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 106 | 0.110 |
Why?
|
| Models, Immunological | 1 | 2014 | 86 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2015 | 375 | 0.100 |
Why?
|
| Hospitalization | 1 | 2021 | 1368 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 544 | 0.100 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 268 | 0.100 |
Why?
|
| Spleen | 3 | 2019 | 482 | 0.100 |
Why?
|
| Risk Factors | 2 | 2020 | 5339 | 0.100 |
Why?
|
| Calcium Signaling | 1 | 2015 | 164 | 0.100 |
Why?
|
| Interleukin-1 | 3 | 2021 | 156 | 0.100 |
Why?
|
| Cell Nucleus | 2 | 2019 | 632 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 178 | 0.100 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2013 | 81 | 0.100 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2003 | 143 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2005 | 1494 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2003 | 386 | 0.090 |
Why?
|
| Splenomegaly | 1 | 2011 | 22 | 0.090 |
Why?
|
| Myeloid Cells | 1 | 2012 | 93 | 0.090 |
Why?
|
| Hydrolysis | 2 | 2003 | 147 | 0.090 |
Why?
|
| Immunoglobulin G | 5 | 2007 | 463 | 0.090 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2002 | 55 | 0.090 |
Why?
|
| Cellular Senescence | 1 | 2012 | 112 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2002 | 128 | 0.090 |
Why?
|
| Autoimmune Lymphoproliferative Syndrome | 1 | 2010 | 1 | 0.080 |
Why?
|
| Phenotype | 2 | 2024 | 1222 | 0.080 |
Why?
|
| Immune Tolerance | 1 | 2011 | 181 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2012 | 1621 | 0.080 |
Why?
|
| T-Box Domain Proteins | 1 | 2010 | 38 | 0.080 |
Why?
|
| Cell Death | 2 | 2019 | 286 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2002 | 329 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 460 | 0.080 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 775 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2010 | 247 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2011 | 405 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 727 | 0.070 |
Why?
|
| Gamma Rays | 1 | 2007 | 32 | 0.070 |
Why?
|
| Zinc | 2 | 1998 | 93 | 0.070 |
Why?
|
| Cell Survival | 2 | 2019 | 582 | 0.060 |
Why?
|
| Lupus Vulgaris | 1 | 2006 | 3 | 0.060 |
Why?
|
| Biofilms | 2 | 2019 | 83 | 0.060 |
Why?
|
| Mice, Mutant Strains | 3 | 2020 | 302 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 679 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2006 | 114 | 0.060 |
Why?
|
| Binding Sites, Antibody | 1 | 2005 | 22 | 0.060 |
Why?
|
| Receptors, IgG | 1 | 2005 | 41 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 114 | 0.060 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 1995 | 33 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2011 | 697 | 0.060 |
Why?
|
| Quinazolines | 1 | 2024 | 22 | 0.050 |
Why?
|
| CD40 Antigens | 2 | 2019 | 60 | 0.050 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2003 | 50 | 0.050 |
Why?
|
| Antigens, Nuclear | 1 | 2003 | 20 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 375 | 0.050 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2003 | 53 | 0.050 |
Why?
|
| Fibrosis | 1 | 2024 | 162 | 0.050 |
Why?
|
| Data Accuracy | 1 | 2024 | 31 | 0.050 |
Why?
|
| Blood Platelets | 2 | 1995 | 104 | 0.050 |
Why?
|
| Rheumatoid Factor | 3 | 2002 | 13 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 495 | 0.050 |
Why?
|
| Keratinocytes | 1 | 2003 | 65 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 106 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2023 | 134 | 0.050 |
Why?
|
| International Classification of Diseases | 1 | 2024 | 135 | 0.050 |
Why?
|
| Patients | 1 | 2024 | 113 | 0.050 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 30 | 0.050 |
Why?
|
| Anisomycin | 1 | 2002 | 6 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 23 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2023 | 458 | 0.050 |
Why?
|
| Histones | 1 | 2005 | 486 | 0.050 |
Why?
|
| Urban Health | 1 | 1982 | 41 | 0.050 |
Why?
|
| Health | 1 | 1982 | 31 | 0.050 |
Why?
|
| DNA | 2 | 2023 | 844 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2021 | 119 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2021 | 38 | 0.040 |
Why?
|
| Macrophages, Peritoneal | 1 | 2001 | 77 | 0.040 |
Why?
|
| Philadelphia | 1 | 2020 | 24 | 0.040 |
Why?
|
| Bias | 1 | 2021 | 114 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2019 | 1130 | 0.040 |
Why?
|
| Thrombophilia | 1 | 2020 | 14 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2020 | 47 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2020 | 75 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2021 | 324 | 0.040 |
Why?
|
| Early Medical Intervention | 1 | 2020 | 20 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2001 | 237 | 0.040 |
Why?
|
| Transplantation Chimera | 1 | 2020 | 41 | 0.040 |
Why?
|
| Macrophages | 1 | 2006 | 1053 | 0.040 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 1999 | 10 | 0.040 |
Why?
|
| Serine | 1 | 2020 | 91 | 0.040 |
Why?
|
| Molecular Mimicry | 1 | 2019 | 31 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 1999 | 112 | 0.040 |
Why?
|
| Glutathione | 1 | 1999 | 56 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 129 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 154 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2020 | 191 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2019 | 53 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2019 | 56 | 0.040 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2020 | 104 | 0.040 |
Why?
|
| Genome, Human | 1 | 2021 | 240 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 72 | 0.040 |
Why?
|
| Imidazoles | 1 | 2019 | 84 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 97 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1998 | 22 | 0.040 |
Why?
|
| Chronic Disease | 1 | 1982 | 756 | 0.040 |
Why?
|
| Immune Sera | 1 | 1998 | 35 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2018 | 37 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2015 | 668 | 0.040 |
Why?
|
| Anxiety | 1 | 2021 | 430 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2019 | 244 | 0.030 |
Why?
|
| Solubility | 1 | 1998 | 189 | 0.030 |
Why?
|
| Genomics | 1 | 2021 | 379 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2019 | 229 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2019 | 174 | 0.030 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1998 | 68 | 0.030 |
Why?
|
| Volition | 1 | 1997 | 10 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 288 | 0.030 |
Why?
|
| Saccades | 1 | 1997 | 15 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 210 | 0.030 |
Why?
|
| Microbiota | 1 | 2019 | 136 | 0.030 |
Why?
|
| Oculomotor Muscles | 1 | 1997 | 11 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 948 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 788 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 237 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 46 | 0.030 |
Why?
|
| Copper | 1 | 1998 | 53 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2019 | 433 | 0.030 |
Why?
|
| Biliopancreatic Diversion | 1 | 1996 | 2 | 0.030 |
Why?
|
| Mutation | 2 | 2002 | 2629 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1383 | 0.030 |
Why?
|
| Arthritis | 1 | 1996 | 53 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2015 | 35 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 163 | 0.030 |
Why?
|
| Allografts | 1 | 2015 | 47 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 1769 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 93 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1995 | 48 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 41 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 1995 | 76 | 0.030 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 1995 | 3 | 0.030 |
Why?
|
| ORAI1 Protein | 1 | 2015 | 4 | 0.030 |
Why?
|
| Stromal Interaction Molecule 1 | 1 | 2015 | 6 | 0.030 |
Why?
|
| Polymerization | 1 | 2015 | 36 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 1996 | 93 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 209 | 0.030 |
Why?
|
| Bone Density | 1 | 1995 | 137 | 0.030 |
Why?
|
| Chickens | 1 | 2015 | 94 | 0.030 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 1994 | 11 | 0.030 |
Why?
|
| Posture | 1 | 1995 | 126 | 0.030 |
Why?
|
| Transcriptome | 1 | 2018 | 396 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 614 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 1297 | 0.030 |
Why?
|
| Cell Line | 2 | 2015 | 2055 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1998 | 342 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 870 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 1407 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 175 | 0.030 |
Why?
|
| Aging | 2 | 2011 | 754 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 431 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2478 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 356 | 0.020 |
Why?
|
| c-Mer Tyrosine Kinase | 2 | 2002 | 3 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 2616 | 0.020 |
Why?
|
| CD4-CD8 Ratio | 1 | 2011 | 16 | 0.020 |
Why?
|
| Lymphocyte Subsets | 1 | 2011 | 37 | 0.020 |
Why?
|
| Immunoglobulin M | 3 | 1998 | 115 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 151 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2011 | 226 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1996 | 1294 | 0.020 |
Why?
|
| Time Factors | 2 | 2012 | 3724 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2010 | 290 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 6726 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 443 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 883 | 0.020 |
Why?
|
| B7-2 Antigen | 1 | 2006 | 32 | 0.020 |
Why?
|
| Adolescent | 4 | 1996 | 6304 | 0.020 |
Why?
|
| B7-1 Antigen | 1 | 2006 | 74 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 2005 | 12 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 192 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2005 | 47 | 0.010 |
Why?
|
| Liposomes | 1 | 2006 | 107 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 891 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 869 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 2002 | 2 | 0.010 |
Why?
|
| Cardiolipins | 1 | 2002 | 6 | 0.010 |
Why?
|
| Rhodamines | 1 | 2002 | 20 | 0.010 |
Why?
|
| Proteinuria | 1 | 2002 | 43 | 0.010 |
Why?
|
| Mitochondria | 1 | 2005 | 384 | 0.010 |
Why?
|
| Brazil | 1 | 1982 | 100 | 0.010 |
Why?
|
| Cytochalasin B | 1 | 2001 | 24 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 2001 | 58 | 0.010 |
Why?
|
| Receptors, Fc | 1 | 2001 | 24 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2001 | 110 | 0.010 |
Why?
|
| Listeria monocytogenes | 1 | 2001 | 34 | 0.010 |
Why?
|
| Microspheres | 1 | 2001 | 57 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2001 | 110 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2001 | 140 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2001 | 212 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 203 | 0.010 |
Why?
|
| Health Surveys | 1 | 1982 | 314 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2001 | 207 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 1982 | 788 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 901 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1982 | 1019 | 0.010 |
Why?
|
| Ceruloplasmin | 1 | 1998 | 3 | 0.010 |
Why?
|
| Blood Sedimentation | 1 | 1998 | 7 | 0.010 |
Why?
|
| src Homology Domains | 1 | 1998 | 21 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1998 | 55 | 0.010 |
Why?
|
| Acute-Phase Proteins | 1 | 1998 | 34 | 0.010 |
Why?
|
| Complement C3 | 1 | 1998 | 59 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1998 | 165 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1998 | 78 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1998 | 296 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 365 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 386 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 518 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 416 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 205 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 1998 | 144 | 0.010 |
Why?
|
| Platelet Count | 1 | 1995 | 26 | 0.010 |
Why?
|
| Base Sequence | 1 | 1998 | 1332 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1998 | 616 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 1597 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 1997 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1982 | 2737 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 486 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1995 | 1102 | 0.010 |
Why?
|
| Child | 1 | 1994 | 4583 | 0.000 |
Why?
|